EUVIMEDEUVIMED entdecken
Crossref

Nucleolar and coiled-body phosphoprotein 1 enhances the induction of CYP3A4 by promoting nuclear translocation of pregnane X receptor

Kyoka Nagaoka, Masataka Nakano, Kiamu Kurosawa, Yuichiro Higuchi, Shotaro Uehara, Nao Yoneda, Hiroshi Suemizu, Tatsuki Fukami, Miki Nakajima

Drug Metabolism and Disposition · 2026-08 · 54 (8) · 100350

DOI: 10.1016/j.dmd.2026.100350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-08. Verfasst von Kyoka Nagaoka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan. Hauptthemen laut MEDLINE: Pregnane X Receptor, Cytochrome P-450 CYP3A, Cell Nucleus, Phosphoproteins. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Government of Japan Ministry of Education Culture Sports Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pregnane X receptor (PXR) is a xenobiotic-sensing nuclear receptor that plays a central role in the regulation of drug-metabolizing enzymes and transporters. Under basal conditions, PXR is predominantly localized in the cytoplasm. Upon activation by ligands such as rifampicin, PXR translocates into the nucleus and induces the transcription of its target genes, including CYP3A4, a major drug-metabolizing enzyme in the human liver. From our previous proteomic analysis of coimmunoprecipitated proteins obtained from lysates of rifampicin-treated ShP51 cells (a HepG2 cell line stably expressing human PXR) using an anti-PXR antibody, we identified nucleolar and coiled-body phosphoprotein 1 (NOLC1), a protein known to shuttle among the cytoplasm, nucleus, and nucleolus, as a potential PXR-interacting factor. This study aimed to clarify the role of NOLC1 in PXR nuclear translocation. Knockdown of NOLC1 in ShP51 cells or HepaSH cells (primary hepatocytes from humanized-liver mice) attenuated the rifampicin-induced expression and activity of CYP3A4, suggesting that NOLC1 positively regulates PXR-mediated CYP3A4 induction. Rifampicin significantly increased luciferase activity driven by the promoter and distal enhancer regions of the CYP3A4 gene; however, this induction was diminished by NOLC1 knockdown in ShP51 cells. Furthermore, immunofluorescence staining of HepaSH cells revealed that rifampicin promoted PXR nuclear translocation, whereas this effect was suppressed by NOLC1 knockdown. Taken together, these findings demonstrate that NOLC1 facilitates the ligand-dependent nuclear translocation and transcriptional activity of PXR, thereby functioning as a regulatory factor for drug metabolism in the human liver. SIGNIFICANCE STATEMENT: This study demonstrates that nucleolar and coiled-body phosphoprotein 1 promotes ligand-dependent pregnane X receptor (PXR) nuclear translocation, enhances PXR recruitment to chromatin, and increases PXR-mediated transactivation, thereby enhancing the induction of CYP3A4 expression. These findings provide mechanistic insight into potential strategies for mitigating PXR-mediated adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnane X ReceptorCytochrome P-450 CYP3ACell NucleusPhosphoproteinsNuclear ProteinsHumansAnimalsMiceActive Transport, Cell NucleusHepatocytesHep G2 CellsRifampinEnzyme InductionReceptors, SteroidProtein Transport

Stichwörter der Autor:innen

Cytochrome P450Drug metabolismNuclear translocationNucleolar and coiled-body phosphoprotein 1Pregnane X receptorShuttling protein

Substanzen

Pregnane X ReceptorCytochrome P-450 CYP3ACYP3A4 protein, humanPhosphoproteinsRifampinNuclear ProteinsReceptors, Steroid

Autor:innen und Institutionen

  • Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan.
  • Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa, Japan.…
  • Central Institute for Experimental Medicine and Life Science (CIEM), Kawasaki, Japan.
  • Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa, Japan.

Förderung

  • Government of Japan Ministry of Education Culture Sports Science and Technology

Zitieren

APA

Nagaoka, K., Nakano, M., Kurosawa, K., Higuchi, Y., Uehara, S., Yoneda, N., Suemizu, H., Fukami, T., & Nakajima, M. (2026). Nucleolar and coiled-body phosphoprotein 1 enhances the induction of CYP3A4 by promoting nuclear translocation of pregnane X receptor. Drug Metabolism and Disposition, 54(8), 100350. https://doi.org/10.1016/j.dmd.2026.100350

Vancouver

Nagaoka K, Nakano M, Kurosawa K, Higuchi Y, Uehara S, Yoneda N, et al. Nucleolar and coiled-body phosphoprotein 1 enhances the induction of CYP3A4 by promoting nuclear translocation of pregnane X receptor. Drug Metabolism and Disposition. 2026;54(8):100350. doi:10.1016/j.dmd.2026.100350

BibTeX
@article{Nagaoka2026,
  author = {Nagaoka, Kyoka and Nakano, Masataka and Kurosawa, Kiamu and Higuchi, Yuichiro and Uehara, Shotaro and Yoneda, Nao and Suemizu, Hiroshi and Fukami, Tatsuki and Nakajima, Miki},
  title = {Nucleolar and coiled-body phosphoprotein 1 enhances the induction of CYP3A4 by promoting nuclear translocation of pregnane X receptor},
  journal = {Drug Metabolism and Disposition},
  year = {2026},
  volume = {54},
  number = {8},
  pages = {100350},
  doi = {10.1016/j.dmd.2026.100350}
}
Kostenlos starten →